Matt Sinderbrand is the SVP and Chief Product Officer for Hu-manity.co. He is formerly the CEO and co-founder of Betterpath Health which was acquired by Hu-manity.co on April 30, 2019.
Matt is on a mission to solve one of the healthcare industry's greatest challenges: lack of access to complete medical data.
Matt's goal is to use technology to capture and contextualize healthcare's “Dark Data" - the healthcare data that's largely unstructured in hospital silos and unable to be accessed by doctors and researchers.
His passion for solving the “Dark Data” problem is not simply a professional endeavour but also a personal one. Nearly a decade ago Matt's sister was diagnosed with a chronic disease that left their family paralyzed due to a "throw it against the wall and see what sticks" treatment strategy. Experiencing the antithesis of data-driven medicine first-hand has catalyzed Matt to become a champion of "what's possible" in healthcare.
Matt has spent years exploring all avenues that relate to the coordination and application of health data to benefit patients and the myriad of stakeholders that currently suffer from insufficient data access. This relentless focus on a singular vision has provided Matt with an intimate understanding of the different mechanics governing our many disconnected health systems, and given him an often unseen perspective of healthcare's deepest, most intractable challenges.
He co-founded Betterpath in 2012 to provide chronic disease patients with free, lifetime medical records, in an effort to determine what treatments work best, for whom, and when. Since that time, he’s helped Betterpath address crucial barriers to health data access and interoperability, and brought several consumer-facing healthcare technologies to market in autoimmune (2014) and rare disease (2015-16).
Now, Matt is singularly focused on integrating Betterpath’s core technology into Hu-manity.co's transformative efforts to empower individuals to gain greater control and derive value from the data they rightfully own while accelerating and deepening research for pharma companies. He holds an MPH from the University of Denver, is a Certified HIPAA Security Expert (CHSE), and is a contributing author on several patents and research protocols.